DEERFIELD, Ill. — Net earnings at Walgreen Co. fell by 25% to $413 million in the fiscal first quarter as a result of declines in prescription volume and front-end sales as well as shifts to generic drugs. Walgreen said prescription sales decreased by 7.2% compared with the first quarter last year, but rebounded from an 8% drop in the fourth quarter, indicating some recovery as a result of a settlement reached over the summer with pharmacy benefits manager Express Scripts. ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

WhyRegisterfor FREE?

Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.

Click here to read the FAQ page if you have any questions (opens in a new window)

Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.